Previous 10 | Next 10 |
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2021 financial results and provide a corporate update on Wednesday, November 10, 2021 at 4...
San Diego, California--(Newsfile Corp. - October 26, 2021) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) securities between December 27, 2018 and August 5, 2021, inclusive (the "Class Period"...
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced the presentation of preclinical data demonstrating the synergistic impact of poziotinib when combined with KRAS inhibitors in KRAS G12C mutant spe...
WASHINGTON, DC / ACCESSWIRE / October 4, 2021 / Cohen Milstein Sellers & Toll PLLC is investigating Spectrum Pharmaceuticals, Inc. (NYSE:SPPI) ("Spectrum Pharmaceuticals" or the "Company") following the filing of class action lawsuits alleging violations of federal securities law. I...
Gainers: FIXX +9.8%. DTIL +7.6%. REGI +5.3%. SPPI +5.2%. RANI +4.7%. Losers: EAR -51.2%. SYBX -8.9%. GRIN -6.4%. QRVO -6.4%. FA -5.0%. For further details see: FIXX, DTIL, EAR and SYBX among after hours movers
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that management will participate in the 2021 Cantor Virtual Global Healthcare Conference. A fireside chat is scheduled for Wednesday, September 29, 20...
The major U.S. equity averages saw significant weakness in Monday's pre-market trading, led lower by a drop in Chinese stocks. JD.com, Inc. (NASDAQ:JD), Alibaba (NYSE:BABA) and Baidu (NASDAQ:BIDU) were among the high-profile names losing ground. Other stocks fell on company-specific headlines...
ZIVO Bioscience (NASDAQ:ZIVO) +175%. Verastem (NASDAQ:VSTM) +22% Oncology's VS-6766 + defactinib combo shows promising action in ovarian cancer study Edesa Biotech (NASDAQ:EDSA) +33% announces positive phase 2 data of its monoclonal antibody in hospitalized COVID-19 patients ER...
Are Biotech Penny Stocks On Your Watch List This Week? Penny stocks are well known for their volatility swings. Whether we’re talking about stocks with insider trading, meme stocks, or penny stocks with high analyst ratings, there are myriad catalysts to seek out. However, sp...
Early data from Cohort 4 of the ongoing ZENITH20 clinical trial shows ORR of 44% in 48 first-line patients treated with 16mg of poziotinib once daily Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology thera...
News, Short Squeeze, Breakout and More Instantly...
Spectrum Pharmaceuticals Inc. Company Name:
SPPI Stock Symbol:
NASDAQ Market:
Spectrum Pharmaceuticals Inc. Website:
New York, New York--(Newsfile Corp. - December 14, 2022) - Levi & Korsinsky, LLP notifies investors in Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI) of a class action securities lawsuit. The lawsuit on behalf of Spectrum investors has been commenced in the the...
NEW YORK, NY / ACCESSWIRE / December 12, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ:SPPI) and reminds investors of the February 3, 2023 deadline to seek th...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Spectrum To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - December 7, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...